Assessments of a health-related matter of interest, importance, or worry to a patient, patient’s authorized representative, or patient’s healthcare provider that could identify a need, problem, or condition.

Data Element

Pain Assessment

Comment

CMS-CCSQ Recommends Advancing Pain Assessment to USCDI

Recommendation:  CMS CCSQ recommends advancing Pain Assessment to Level 2 and include in USCDI v8. CMS CCSQ also recommends updating the description for Pain Assessment to make clear that the data element captures both the assessment conducted and the results of the assessment.

Rationale: 

  1. Lack of standardization of pain assessment data in clinical care: Although pain information is routinely collected in healthcare, the content and methods used to assess pain are not consistently standardized across care settings (e.g., cancer centers)  and populations (e.g., pediatric ICU patients). Existing standardized data often focus on individual aspects of pain, such as severity or interference with activities, rather than consistently representing comprehensive pain assessments. Establishing Pain Assessment as a USCDI data element would provide a common interoperability target for clinically meaningful pain assessment information and results, helping make these data more consistently structured, computable, and shareable across settings.
  2. Pain impacts a large proportion of the US population: Many people across the country experience pain and seek care for pain, making it an important piece of information gathered during clinical encounters. The CDC estimated that among the adult U.S. population about 20% experienced chronic pain in 2019-2021, increasing to about 24% in 2023, and 30-40% experienced limb or back pain in 2019; 8.5% have high-impact chronic pain that impacts 1 or more major life activities. A recent study found that higher pain intensity was associated with increased healthcare utilization, including office visits, emergency department usage, and inpatient admission. 
  3. Pain is intertwined with other conditions: Pain is often associated with or indicative of other conditions, including mental health conditions, cancer, and other comorbidities. Therefore, there is a necessity to capture and share pain data across disciplines and settings.
  4. Better pain assessment --> better pain management --> better patient outcomes: Effective pain management through standardized assessments is key to supporting patient outcomes, especially in the midst of the continuing opioid epidemic, which has been fueled in part by mis- and over-prescribing opioid medications for pain and has led to changes in opioid prescribing practices.
  5. Pain assessments are captured in several terminologies, including:
    1. LOINC: 101603-9 CMS pain assessment panel, 38213-5 FLACC pain assessment panel for children, 103780-3 Pain assessment in advanced dementia
    2. SNOMED CT: Various procedures, such as 225399009 Pain assessment (procedure), 423184003 Adult pain assessment (procedure), and 423401003 Pediatric pain assessment (procedure); various pain assessment scales such as 1284852002 Numeric Pain Rating Scale (assessment scale) and the 273593005 | McGill pain chart questionnaire (assessment scale); various ways to capture scale scores such as 443223005 Brief pain inventory score (observable entity) and 1344631005 Pain Assessment in Advanced Dementia scale score (observable entity).
  6. FHIR R4 Symptoms Implementation Guide includes a pain assessment collection and pain assessment score examples, demonstrating how that IG can capture and exchange pain assessment data.
  7. The PACIO Project Personal Functioning and Engagement IG includes a Sensory Functions and Pain Value Set, supporting collection and exchange of pain assessment data.
  8. Current Use and Exchange (Level 2): FHIR R4 APIs for Oracle Health Millennium Platform includes a pain assessment as an example of a service request. Epic includes in their FHIR API Specifications page an example of pain assessments and findings captured in SmartData included in Observation.Search (SmartData Elements) (R4). Atrium Health and MultiCare use SeamlessMD to collect patient-reported outcomes, including pain – “Through the integration of SeamlessMD and Epic, using SMART on FHIR and HL7v2 feeds, providers can easily enroll patients into SeamlessMD and remotely monitor patients from right within the Epic patient chart.”
  9. Breadth of Applicability (Level 2): Completing pain assessments or using pain assessment findings are key components of patient care across all care settings and all clinician disciplines. The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) “requires that standardized patient assessment data elements (SPADEs) be collected across post-acute care (PAC).” To support this, every Medicaid- and Medicare-certified nursing facility is required to collect and report data for pain via the MDS (Section J); there are similar requirements for home health via the OASIS (Section J), long-term care via the CARE dataset (Section J), and inpatient rehabilitation facilities via the IRF-PAI (Section J). There is a CMS Electronic Clinical Quality Measure (eCQM) for “Oncology: Medical and Radiation - Pain Intensity Quantified” (CMS157v14). While there is not a federally-mandated pain assessment requirement for acute care hospitals, there are requirements related to pain assessment and management for accreditation by The Joint Commission accreditation and Accreditation Commission for Health Care (ACHC) (ACHC Standard 16.01.02 “Pain assessment and reassessment”).

CMS-CCSQ Supports the Advancement of Pain Assessment to Level 2

Recommendation:  CMS CCSQ recommends the Pain Assessment element be advanced to Level 2.

Rationale: Upgrading the Pain Assessment data element to Level 2 in the USCDI is crucial for improving care and captured in the International Classification of Functioning, Disability and Health (ICF) where effective pain management is essential for enhancing patient outcomes and quality of life. Additionally, this data is required by CMS for PAC setting quality reporting programs. Comprehensive pain assessment is necessary to ensure tailored and effective care for both acute and chronic pain management. These assessments which include evaluating pain severity, its impact on daily activities, and its effects on sleep and mood, play a critical role in developing individualized care plans. Data elements such as Pain effect on sleep (J0510), Pain interference with therapy activities (J0520), and Pain interference with daily activities (J0350) are already captured and standardized in assessments like the IRF-PAI, MDS, and LCDS, and provide valuable insights into how pain impacts patient functioning and recovery. Elevating Pain Assessment to Level 2 will signal to vendors the importance of capturing this data element in healthcare IT systems and may increase its adoption, thus facilitating better pain management strategies that improve quality of care.

CMS-CCSQ Supports the Advancement of Pain Assessment to Level 2

Recommendation:  CMS CCSQ recommends the Pain Assessment element be advanced to Level 2.

Rationale: Upgrading the Pain Assessment data element to Level 2 in the USCDI is crucial for improving care and captured in the International Classification of Functioning, Disability and Health (ICF) where effective pain management is essential for enhancing patient outcomes and quality of life. Additionally, this data is required by CMS for PAC setting quality reporting programs. Comprehensive pain assessment is necessary to ensure tailored and effective care for both acute and chronic pain management. These assessments which include evaluating pain severity, its impact on daily activities, and its effects on sleep and mood, play a critical role in developing individualized care plans. Data elements such as Pain effect on sleep (J0510), Pain interference with therapy activities (J0520), and Pain interference with daily activities (J0350) are already captured and standardized in assessments like the IRF-PAI, MDS, and LCDS, and provide valuable insights into how pain impacts patient functioning and recovery. Elevating Pain Assessment to Level 2 will signal to vendors the importance of capturing this data element in healthcare IT systems and may increase its adoption, thus facilitating better pain management strategies that improve quality of care.

CMS-CCSQ Recommends the advancement of Pain Assessment to Lv2

Recommendation: CMS CCSQ recommends the Pain Assessment element be advanced to Level 2.

Rationale: Upgrading the Pain Assessment data element to Level 2 in the USCDI is crucial for improving care and captured in the International Classification of Functioning, Disability and Health (ICF) where effective pain management is essential for enhancing patient outcomes and quality of life. Comprehensive pain assessment is necessary to ensure tailored and effective care for both acute and chronic pain management. These assessments which include evaluating pain severity, its impact on daily activities, and its effects on sleep and mood, play a critical role in developing individualized care plans. Data elements such as Pain effect on sleep (J0510), Pain interference with therapy activities (J0520), and Pain interference with daily activities (J0350) are already captured and standardized in assessments like the IRF-PAI, MDS, and LCDS, and provide valuable insights into how pain impacts patient functioning and recovery. Elevating Pain Assessment to Level 2 will signal to vendors the importance of capturing this data element in healthcare IT systems and may increase its adoption, thus facilitating better pain management strategies that improve quality of care.

Log in or register to post comments

Add a New Comment

Review comment and Submit

Edit
Comment #1
PDF, Doc, Docx
Max Size : 10 MB